Stock Events

Stock Events

Search...

Allogene Therapeutics (ALLO) Q1 2026 Earnings

12MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.29

-0.25

-0.21

-0.17

Details

Expected EPS

-0.225512

Actual EPS

-0.17

Surprise EPS

0.06

Surprise Percent

+24.62%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.17 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.